| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |